BidaskScore Cuts Veracyte (VCYT); Special Opportunities Fund (SPE) Has 1 Sentiment

Veracyte, Inc. (NASDAQ:VCYT) Logo

Special Opportunities Fund (SPE) investors sentiment decreased to 1 in 2019 Q2. It’s down -0.50, from 1.5 in 2019Q1. The ratio has dropped, as 9 institutional investors increased and started new stock positions, while 6 sold and reduced equity positions in Special Opportunities Fund. The institutional investors in our database now have: 2.11 million shares, up from 2.04 million shares in 2019Q1. Also, the number of institutional investors holding Special Opportunities Fund in top ten stock positions was flat from 1 to 1 for the same number . Sold All: 3 Reduced: 3 Increased: 7 New Position: 2.

Veracyte (NASDAQ:VCYT)‘s old rating is no longer valid. BidaskScore cut Veracyte (NASDAQ:VCYT)‘s rating to Hold.

Analysts await Veracyte, Inc. (NASDAQ:VCYT) to report earnings on February, 24. They expect $-0.08 earnings per share, 0.00% or $0.00 from last year’s $-0.08 per share. After $-0.02 actual earnings per share reported by Veracyte, Inc. for the previous quarter, Wall Street now forecasts 300.00% negative EPS growth.

More notable recent Veracyte, Inc. (NASDAQ:VCYT) news were published by: which released: “Did Business Growth Power Veracyte’s (NASDAQ:VCYT) Share Price Gain of 255%? – Yahoo Finance” on December 04, 2019, also with their article: “Peninsula diagnostics company’s overseas plans could more than triple revenue – San Francisco Business Times” published on December 04, 2019, published: “Commit To Buy Veracyte At $20, Earn 18.1% Annualized Using Options – Nasdaq” on November 05, 2019. More interesting news about Veracyte, Inc. (NASDAQ:VCYT) were released by: and their article: “Loss-Making Veracyte, Inc. (NASDAQ:VCYT) Expected To Breakeven – Yahoo Finance” published on September 10, 2019 as well as‘s news article titled: “Is Veracyte, Inc.’s (NASDAQ:VCYT) CEO Pay Justified? – Yahoo Finance” with publication date: July 17, 2019.

Since August 9, 2019, it had 0 insider buys, and 1 insider sale for $395,681 activity. Shares for $395,681 were sold by JONES EVAN/ FA.

Veracyte, Inc. operates as a genomic diagnostics firm in the United States. The company has market cap of $1.37 billion. The firm uses genomic technology to resolve diagnostic uncertainty. It currently has negative earnings. It offers Afirma Thyroid FNA Analysis solution; cytopathology testing services; and the Afirma Malignancy Classifiers to manage thyroid nodule patients.

The stock increased 6.85% or $1.8 during the last trading session, reaching $28.06. About 540,018 shares traded. Veracyte, Inc. (NASDAQ:VCYT) has risen 160.99% since December 4, 2018 and is uptrending. It has outperformed by 160.99% the S&P500. Some Historical VCYT News: 19/05/2018 – Veracyte: Data From Studies Show ‘Real-World’ Value of Afirma Genomic Sequencing Classifier in Thyroid Cancer; 19/05/2018 – Veracyte: Afirma GSC Identified Significantly More Benign Thyroid Nodules Among Those Deemed Indeterminate; 11/04/2018 – VERACYTE: LOXO TO USE ITS AFIRMA XPRESSION ATLAS PLATFORM; 19/03/2018 – Veracyte Unveils Afirma Xpression Atlas Platform at ENDO 2018; 17/05/2018 – Veracyte Launches Early Access Program for Envisia Genomic Classifier to Improve Diagnosis of IPF; 11/04/2018 – VERACYTE – LOXO ONCOLOGY WILL ACCESS VERACYTE’S NEW AFIRMA XPRESSION ATLAS PLATFORM AS PER DEAL; 17/04/2018 – Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on Tuesday, May 1, 2018; 22/04/2018 – DJ Veracyte Inc, Inst Holders, 1Q 2018 (VCYT); 19/03/2018 – Veracyte Announces New Data Suggesting Afirma GSC’s Ability to Help Significantly More Patients Avoid Unnecessary Thyroid Surgery; 11/04/2018 – VERACYTE INC – FINANCIAL AND OTHER TERMS OF AGREEMENT WERE NOT DISCLOSED

Investors sentiment decreased to 1.31 in Q2 2019. Its down 1.15, from 2.46 in 2019Q1. It is negative, as 12 investors sold Veracyte, Inc. shares while 36 reduced holdings. 56 funds opened positions while 62 raised stakes. 42.16 million shares or 40.52% more from 30.00 million shares in 2019Q1 were reported. Next Century Growth Limited Liability has invested 2.68% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT). Bnp Paribas Arbitrage Sa reported 0% stake. Alliancebernstein L P holds 62,300 shares or 0% of its portfolio. C M Bidwell Associate Limited accumulated 3,355 shares or 0.1% of the stock. Clarivest Asset Mngmt has invested 0.03% in Veracyte, Inc. (NASDAQ:VCYT). Quantbot Technology Limited Partnership owns 1,100 shares or 0% of their US portfolio. Barclays Public Ltd Com accumulated 49,384 shares. First Light Asset Mgmt Ltd Liability Com accumulated 2.33% or 589,099 shares. Glenmede Tru Communication Na reported 49 shares or 0% of all its holdings. Vanguard Gp Inc owns 0% invested in Veracyte, Inc. (NASDAQ:VCYT) for 2.30M shares. Amer Century Incorporated owns 102,662 shares or 0% of their US portfolio. Convergence Inv Llc holds 0.04% or 5,223 shares in its portfolio. Farallon Management Ltd Liability Corporation reported 350,000 shares. Strs Ohio stated it has 0% in Veracyte, Inc. (NASDAQ:VCYT). Principal has invested 0% in Veracyte, Inc. (NASDAQ:VCYT).

Special Opportunities Fund, Inc. is a close-ended balanced fund of funds launched and managed by Bulldog Investors, LLC. The company has market cap of $123.22 million. It invests in close-ended funds investing in public equity and fixed income markets. It has a 36.7 P/E ratio. The fund employs a combination of value, opportunistic and special situations strategies to make its investments.

The stock increased 0.66% or $0.1 during the last trading session, reaching $14.49. About 26,939 shares traded or 92.15% up from the average. Special Opportunities Fund, Inc. (SPE) has 0.00% since December 4, 2018 and is . It has by 0.00% the S&P500.

More notable recent Special Opportunities Fund, Inc. (NYSE:SPE) news were published by: which released: “Stocks That Hit 52-Week Highs On Monday – Benzinga” on December 02, 2019, also with their article: “Special Opportunities Fund, Inc. Annual Stockholders Meeting – Business Wire” published on November 15, 2019, published: “SPE: Regular Distribution Imminent – Seeking Alpha” on March 15, 2019. More interesting news about Special Opportunities Fund, Inc. (NYSE:SPE) were released by: and their article: “Western Asset Corporate Loan Fund Inc. Announces Ability to Invest in Collateralized Loan Obligations – Business Wire” published on November 15, 2019 as well as‘s news article titled: “Special Opportunities Fund: Buying Discounted Funds With An Extra Discount And Catalysts – Seeking Alpha” with publication date: May 28, 2019.

Veracyte, Inc. (NASDAQ:VCYT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.